Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMMX Immix Biopharma, Inc

交易中 05-08 14:20:16 EDT

2.21

+0.00

0.00%

最高2.30	最低2.14	成交量4.71万
今开2.20	昨收2.21	日振幅7.24%
总市值5,835万	流通市值3,115万	总股本2,640万
成交额10.41万	换手率0.33%	流通股本1,410万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMMX","market":"US","secType":"STK","nameCN":"Immix Biopharma, Inc","latestPrice":2.21,"timestamp":1715192399462,"preClose":2.21,"halted":0,"volume":47080,"delay":0,"floatShares":14096487,"shares":26404063,"eps":-0.889563,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"05-08 14:20:16 EDT","open":2.2,"high":2.2999,"low":2.14,"amount":104120.26834,"amplitude":0.072353,"askPrice":2.22,"askSize":100,"bidPrice":2.2,"bidSize":21,"shortable":3,"etf":0,"ttmEps":-0.889563,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1715198400000},"adr":0,"listingDate":1639630800000,"adjPreClose":2.21,"postHourTrading":{"tag":"盘后","latestPrice":2.21,"preClose":2.21,"latestTime":"18:08 EDT","volume":115,"amount":253.5,"timestamp":1715119739983},"volumeRatio":0.689206},"requestUrl":"/m/hq/s/IMMX/tweets","defaultTab":"tweets","newsList":[{"id":"2433789503","title":"Immix Biopharma, Inc.盘中异动 早盘大幅跳水5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433789503","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433789503?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:47","pubTimestamp":1715093231,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时47分，Immix Biopharma, Inc.股票出现波动，股价急速下跌5.58%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，珐博进、Lexaria Bioscience Corp C/Wts 14/01/2026 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Clearmind Medicine Inc.、Tc Biopharm  Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为1391.24%、169.03%、167.61%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、珐博进、Clearmind Medicine Inc.，振幅分别为41.69%、41.38%、37.61%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722471179264d68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722471179264d68&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432988757","title":"Immix Biopharma, Inc.盘中异动 早盘大幅上涨6.91%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432988757","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432988757?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:49","pubTimestamp":1714661357,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日22时49分，Immix Biopharma, Inc.股票出现异动，股价快速上涨6.91%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Allarity Therapeutics, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为3491.99%、548.88%、141.77%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Aptevo Therapeutics Inc.，振幅分别为126.28%、52.87%、33.33%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502224917861eab56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502224917861eab56&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431329452","title":"Immix Biopharma, Inc.盘中异动 早盘快速拉升5.19%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431329452","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431329452?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:53","pubTimestamp":1714485195,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日21时53分，Immix Biopharma, Inc.股票出现波动，股价急速拉升5.19%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为625.76%、195.02%、11.13%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Senti Biosciences, Inc.、Dare Bioscience, Inc.，振幅分别为46.79%、24.41%、23.06%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430215315861ea6da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430215315861ea6da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431786644","title":"Immix Biopharma, Inc.盘中异动 大幅上涨8.92%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431786644","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431786644?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:39","pubTimestamp":1714397946,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时39分，Immix Biopharma, Inc.股票出现异动，股价急速拉升8.92%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Soleno Therapeutics, Inc.、Immunitybio, Inc.、Cassava Sciences Inc C/Wts 15/11/2024涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为558.35%、24.94%、12.09%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Soleno Therapeutics, Inc.，振幅分别为33.33%、17.43%、14.62%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292139067924ecf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292139067924ecf7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430273855","title":"Immix Biopharma, Inc.盘中异动 股价大涨7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430273855","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430273855?lang=zh_cn&edition=full","pubTime":"2024-04-27 03:10","pubTimestamp":1714158615,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日03时10分，Immix Biopharma, Inc.股票出现波动，股价急速拉升7.14%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Zura Bio Limited C/Wts 涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1510.09%、126.81%、56.84%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Psyence Biomedical Ltd C/Wts 25/01/2029、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为82.78%、81.90%、66.85%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270310157924181d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270310157924181d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430286106","title":"Immix Biopharma, Inc.盘中异动 快速跳水5.16%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430286106","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430286106?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:35","pubTimestamp":1714052122,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时35分，Immix Biopharma, Inc.股票出现异动，股价大幅下挫5.16%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为748.32%、182.09%、6.48%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、凯信远达，振幅分别为27.26%、23.46%、14.75%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252135227a55b374&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252135227a55b374&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429893119","title":"Immix Biopharma, Inc.盘中异动 股价大涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429893119","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429893119?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:51","pubTimestamp":1713883888,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时51分，Immix Biopharma, Inc.股票出现异动，股价急速上涨5.63%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.55%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc致力于发现和开发用于血液系统恶性肿瘤（血癌）和其他适应症的新型细胞疗法。该公司有两个业务部门：ImmixBio和Nexcella。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423225129861e8352&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423225129861e8352&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429384922","title":"Immix Biopharma, Inc.盘中异动 股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429384922","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429384922?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:55","pubTimestamp":1713794104,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时55分，Immix Biopharma, Inc.股票出现异动，股价大幅下跌5.48%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc致力于发现和开发用于血液系统恶性肿瘤（血癌）和其他适应症的新型细胞疗法。该公司有两个业务部门：ImmixBio和Nexcella。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222155047a549548&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222155047a549548&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428165403","title":"Immix Biopharma, Inc.盘中异动 早盘股价大涨5.43%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428165403","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428165403?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:39","pubTimestamp":1713533985,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时39分，Immix Biopharma, Inc.股票出现波动，股价急速拉升5.43%。截至发稿，该股报2.33美元/股，成交量8402股，换手率0.03%，振幅3.62%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc致力于发现和开发用于血液系统恶性肿瘤（血癌）和其他适应症的新型细胞疗法。该公司有两个业务部门：ImmixBio和Nexcella。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192139457921e0bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192139457921e0bf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428859760","title":"Immix Biopharma, Inc.盘中异动 股价大跌5.20%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428859760","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428859760?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:48","pubTimestamp":1713448104,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时48分，Immix Biopharma, Inc.股票出现异动，股价大幅下跌5.20%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc致力于发现和开发用于血液系统恶性肿瘤（血癌）和其他适应症的新型细胞疗法。该公司有两个业务部门：ImmixBio和Nexcella。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418214825861e7147&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418214825861e7147&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428048618","title":"Immix Biopharma, Inc.盘中异动 下午盘大幅跳水5.08%报2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428048618","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428048618?lang=zh_cn&edition=full","pubTime":"2024-04-17 03:04","pubTimestamp":1713294260,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日03时04分，Immix Biopharma, Inc.股票出现波动，股价大幅下挫5.08%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc致力于发现和开发用于血液系统恶性肿瘤（血癌）和其他适应症的新型细胞疗法。该公司有两个业务部门：ImmixBio和Nexcella。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170304217a5332f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170304217a5332f0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426264658","title":"Immix Biopharma, Inc.盘中异动 急速下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426264658","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426264658?lang=zh_cn&edition=full","pubTime":"2024-04-11 23:31","pubTimestamp":1712849475,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日23时31分，Immix Biopharma, Inc.股票出现波动，股价大幅下跌5.20%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc致力于发现和开发用于血液系统恶性肿瘤（血癌）和其他适应症的新型细胞疗法。该公司有两个业务部门：ImmixBio和Nexcella。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041123311587e7fabb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041123311587e7fabb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424821285","title":"Immix Biopharma, Inc.盘中异动 大幅上涨6.46%报3.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424821285","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424821285?lang=zh_cn&edition=full","pubTime":"2024-04-04 00:45","pubTimestamp":1712162753,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日00时45分，Immix Biopharma, Inc.股票出现异动，股价大幅上涨6.46%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc致力于发现和开发用于血液系统恶性肿瘤（血癌）和其他适应症的新型细胞疗法。该公司有两个业务部门：ImmixBio和Nexcella。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040400455487e7dfb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040400455487e7dfb9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423044850","title":"Immix Biopharma Inc    预计每股亏损 23 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2423044850","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2423044850?lang=zh_cn&edition=full","pubTime":"2024-03-30 04:50","pubTimestamp":1711745406,"startTime":"0","endTime":"0","summary":"   * Immix Biopharma Inc    预计在4月1日发布业绩报告时，季度收入将没有变化(预计)，截至2023年12月31日。*    * LSEG的分析师平均预计Immix Biopharma Inc每股亏损23美分。* 分析师对该公司股票的评级为 \"买入\"。* 华尔街对 Immix Biopharma Inc 的 12 个月目标价中位数为 14.00 美元，高于其上一次收盘价 3.07 美元。3月29日 - 本摘要于北京时间 3 月 29 日 20:49 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422885943","title":"Immix Biopharma, Inc.盘中异动 急速拉升6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422885943","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422885943?lang=zh_cn&edition=full","pubTime":"2024-03-28 00:33","pubTimestamp":1711557184,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日00时33分，Immix Biopharma, Inc.股票出现波动，股价快速上涨6.46%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc致力于发现和开发用于血液系统恶性肿瘤（血癌）和其他适应症的新型细胞疗法。该公司有两个业务部门：ImmixBio和Nexcella。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032800330487e7c588&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032800330487e7c588&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422521573","title":"Immix Biopharma Inc    预计每股亏损 23 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2422521573","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422521573?lang=zh_cn&edition=full","pubTime":"2024-03-26 04:03","pubTimestamp":1711397010,"startTime":"0","endTime":"0","summary":"   * Immix Biopharma Inc    预计在3月27日公布截至2023年12月31日的业绩时，季度收入将没有变化(预计)。*    * LSEG的分析师平均预计Immix Biopharma Inc每股亏损23美分。* 分析师对该公司股票的评级为 \"买入\"。* 华尔街对 Immix Biopharma Inc 的 12 个月目标价中位数为 14.00 美元，高于其上次收盘价 3.29 美元。3月25日 - 本摘要于北京时间 3 月 25 日 20:03 机器生成。除非另有说明，所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422052390","title":"Immix Biopharma, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422052390","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422052390?lang=zh_cn&edition=full","pubTime":"2024-03-26 00:43","pubTimestamp":1711384992,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日00时43分，Immix Biopharma, Inc.股票出现异动，股价急速下跌5.17%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Landos Biopharma, Inc.、Clene Inc C/Wts 30/12/2025 、Maia Biotechnology, Inc.涨幅较大，Altamira Therapeutics Ltd.、Xtl生物制药、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为3188.37%、441.34%、75.83%，振幅较大的相关个股有Xtl生物制药、Altamira Therapeutics Ltd.、Zura Bio Limited，振幅分别为78.61%、74.57%、47.80%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc致力于发现和开发用于血液系统恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326004313861e0ed0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326004313861e0ed0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421635824","title":"Immix Biopharma, Inc.盘中异动 大幅拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421635824","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421635824?lang=zh_cn&edition=full","pubTime":"2024-03-23 03:41","pubTimestamp":1711136481,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日03时41分，Immix Biopharma, Inc.股票出现异动，股价大幅拉升5.56%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc致力于发现和开发用于血液系统恶性肿瘤（血癌）和其他适应症的新型细胞疗法。该公司有两个业务部门：ImmixBio和Nexcella。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323034121791c538c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323034121791c538c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421046120","title":"Immix Biopharma, Inc.盘中异动 快速上涨5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421046120","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421046120?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:44","pubTimestamp":1711028645,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时44分，Immix Biopharma, Inc.股票出现异动，股价快速拉升5.84%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc致力于发现和开发用于血液系统恶性肿瘤（血癌）和其他适应症的新型细胞疗法。该公司有两个业务部门：ImmixBio和Nexcella。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214405861e01a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214405861e01a8&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immixbio.com","stockEarnings":[{"period":"1week","weight":0.0184},{"period":"1month","weight":-0.23},{"period":"3month","weight":-0.2706},{"period":"6month","weight":-0.4043},{"period":"1year","weight":-0.0675},{"period":"ytd","weight":-0.6806}],"compareEarnings":[{"period":"1week","weight":0.0302},{"period":"1month","weight":-0.0025},{"period":"3month","weight":0.0382},{"period":"6month","weight":0.192},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.088}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immix Biopharma, Inc.于2014年1月7日成立为特拉华州公司。该公司是一家临床阶段的生物制药公司，在肿瘤学和炎症领域开发一种新型的组织特异性疗法（“TSTx”）TM。该公司的主要资产IMX-110目前正在美国和澳大利亚进行实体瘤的1b/2a期临床试验。","exchange":"NASDAQ","name":"Immix Biopharma, Inc","nameEN":"Immix Biopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immix Biopharma, Inc(IMMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immix Biopharma, Inc,IMMX,Immix Biopharma, Inc股票,Immix Biopharma, Inc股票老虎,Immix Biopharma, Inc股票老虎国际,Immix Biopharma, Inc行情,Immix Biopharma, Inc股票行情,Immix Biopharma, Inc股价,Immix Biopharma, Inc股市,Immix Biopharma, Inc股票价格,Immix Biopharma, Inc股票交易,Immix Biopharma, Inc股票购买,Immix Biopharma, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immix Biopharma, Inc(IMMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}